BIOSBioSenicBIOS info
$0.01info-3.17%24h
Global rank33734
Market cap$1.04M
Change 7d-25.61%
YTD Performance-90.32%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    BioSenic (BIOS) Stock Overview

    BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures' and ArsciCor, which is in Phase III in GvHD is being prepared with an oral treatment. BioSenic S.A. is based in Mont-Saint-Guibert, Belgium.

    BIOS Stock Information

    Symbol
    BIOS
    Address
    Building H (box 24)Mont-Saint-Guibert, 1435Belgium
    Founded
    -
    Trading hours
    -
    Website
    https://www.biosenic.com
    Country
    πŸ‡§πŸ‡ͺ Belgium
    Phone Number
    32 493 09 73 66

    BioSenic (BIOS) Price Chart

    -
    Value:-

    BioSenic Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.006346959920081576
    N/A
    Market Cap
    $1.04M
    N/A
    Shares Outstanding
    163.18M
    N/A
    Employees
    0
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org